The potential for false-positive results was a more frequent topic of discussion in the prostate cancer focus groups, but most men who expressed an opinion were comfortable with the risk of false-positive PSA test results, whereas most women who provided an opinion said they were not comfortable with the risk of false-positive mammogram results. The gene discussed is KLK3; the disease is prostate carcinoma.